SK282103B6 - Farmaceutický prostriedok na liečenie endokrinopatií - Google Patents
Farmaceutický prostriedok na liečenie endokrinopatií Download PDFInfo
- Publication number
- SK282103B6 SK282103B6 SK1184-96A SK118496A SK282103B6 SK 282103 B6 SK282103 B6 SK 282103B6 SK 118496 A SK118496 A SK 118496A SK 282103 B6 SK282103 B6 SK 282103B6
- Authority
- SK
- Slovakia
- Prior art keywords
- treatment
- endocrinopathies
- pharmaceutical composition
- hydrogen
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0057894A AT407608B (de) | 1994-03-18 | 1994-03-18 | Mittel zur behandlung von osteoporose |
| PCT/AT1995/000055 WO1995025522A1 (fr) | 1994-03-18 | 1995-03-20 | Utilisation de derives phosphoriques d'alcaloïdes pour le traitement d'endocrinopathies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK118496A3 SK118496A3 (en) | 1997-05-07 |
| SK282103B6 true SK282103B6 (sk) | 2001-11-06 |
Family
ID=3494294
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1184-96A SK282103B6 (sk) | 1994-03-18 | 1995-03-20 | Farmaceutický prostriedok na liečenie endokrinopatií |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5888991A (fr) |
| EP (1) | EP0750502B1 (fr) |
| JP (1) | JP4130473B2 (fr) |
| AT (2) | AT407608B (fr) |
| AU (1) | AU690232B2 (fr) |
| CA (1) | CA2180717C (fr) |
| CZ (1) | CZ290669B6 (fr) |
| DE (1) | DE59509229D1 (fr) |
| DK (1) | DK0750502T3 (fr) |
| ES (1) | ES2158089T3 (fr) |
| GR (1) | GR3036205T3 (fr) |
| NZ (1) | NZ281889A (fr) |
| PT (1) | PT750502E (fr) |
| SK (1) | SK282103B6 (fr) |
| WO (1) | WO1995025522A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH695417A5 (de) * | 2001-11-15 | 2006-05-15 | Ddr Wassyl Nowicky Dipl Ing | Verfahren zur Umsetzung von Alkaloiden. |
| AT518206A2 (de) | 2016-01-29 | 2017-08-15 | Neovia | Proteinkinase-C-Inhibitor enthaltender Tierfutterzusatz |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT354644B (de) * | 1975-12-19 | 1980-01-25 | Nowicky Wassili | Verfahren zur herstellung von neuen salzen von alkaloidderivaten von thiophosphorsaeure |
| AT377988B (de) * | 1976-06-28 | 1985-05-28 | Nowicky Wassili | Verfahren zur herstellung von neuen phosphorderivaten von alkaloiden |
| GB2110553A (en) * | 1981-12-01 | 1983-06-22 | Willett And Company Limited Th | Pressurized filtration system |
| US4970212A (en) * | 1982-05-18 | 1990-11-13 | Nowicky Wassili | Method of treating human illnesses which compromise the ability to mount an effective immunological response |
| US4816462A (en) * | 1982-05-18 | 1989-03-28 | Nowicky Wassili | Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds |
| US4735945A (en) * | 1986-03-13 | 1988-04-05 | Vipont Laboratories, Inc. | Method for inhibiting bone resorption and collagenase release |
| EP0326627A1 (fr) * | 1988-02-01 | 1989-08-09 | Vipont Pharmaceutical, Inc. | Méthode pour l'inhibition de résorption d'os et libération de collagénase |
-
1994
- 1994-03-18 AT AT0057894A patent/AT407608B/de not_active IP Right Cessation
-
1995
- 1995-03-20 SK SK1184-96A patent/SK282103B6/sk unknown
- 1995-03-20 NZ NZ281889A patent/NZ281889A/en not_active IP Right Cessation
- 1995-03-20 WO PCT/AT1995/000055 patent/WO1995025522A1/fr active IP Right Grant
- 1995-03-20 DE DE59509229T patent/DE59509229D1/de not_active Expired - Fee Related
- 1995-03-20 DK DK95911149T patent/DK0750502T3/da active
- 1995-03-20 JP JP52423895A patent/JP4130473B2/ja not_active Expired - Fee Related
- 1995-03-20 US US08/669,409 patent/US5888991A/en not_active Expired - Lifetime
- 1995-03-20 CA CA002180717A patent/CA2180717C/fr not_active Expired - Fee Related
- 1995-03-20 EP EP95911149A patent/EP0750502B1/fr not_active Expired - Lifetime
- 1995-03-20 ES ES95911149T patent/ES2158089T3/es not_active Expired - Lifetime
- 1995-03-20 CZ CZ19962645A patent/CZ290669B6/cs not_active IP Right Cessation
- 1995-03-20 AU AU18848/95A patent/AU690232B2/en not_active Ceased
- 1995-03-20 PT PT95911149T patent/PT750502E/pt unknown
- 1995-03-20 AT AT95911149T patent/ATE200865T1/de not_active IP Right Cessation
-
2001
- 2001-07-11 GR GR20010401057T patent/GR3036205T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATA57894A (de) | 2000-09-15 |
| DK0750502T3 (da) | 2001-08-06 |
| EP0750502B1 (fr) | 2001-05-02 |
| CA2180717A1 (fr) | 1995-09-28 |
| WO1995025522A1 (fr) | 1995-09-28 |
| SK118496A3 (en) | 1997-05-07 |
| EP0750502A1 (fr) | 1997-01-02 |
| NZ281889A (en) | 1997-04-24 |
| ATE200865T1 (de) | 2001-05-15 |
| AU1884895A (en) | 1995-10-09 |
| DE59509229D1 (de) | 2001-06-07 |
| JPH09510459A (ja) | 1997-10-21 |
| AU690232B2 (en) | 1998-04-23 |
| CA2180717C (fr) | 1999-12-07 |
| JP4130473B2 (ja) | 2008-08-06 |
| US5888991A (en) | 1999-03-30 |
| AT407608B (de) | 2001-05-25 |
| CZ290669B6 (cs) | 2002-09-11 |
| PT750502E (pt) | 2001-09-28 |
| GR3036205T3 (en) | 2001-10-31 |
| ES2158089T3 (es) | 2001-09-01 |
| CZ264596A3 (en) | 1996-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100370258B1 (ko) | 스테로이드호르몬및그것의길항제의영구이온유도체 | |
| CA2165012C (fr) | Agonistes d'oestrogenes | |
| US5470883A (en) | Method of treating peripheral vasoconstriction with tamoxifen citrate | |
| JP2003520817A (ja) | エストロゲンと組み合わせた選択的エストロゲン受容体モジュレータ | |
| CN102264359A (zh) | S1p受体激动剂的给药方案 | |
| Chen et al. | Complications of androgen-deprivation therapy in men with prostate cancer | |
| SK3412000A3 (en) | Method of increasing bone volume using non-naturally-occurring fp selective agonists | |
| US6235774B1 (en) | Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration | |
| CN1142767A (zh) | 2，3-二芳基-1-苯丙吡喃衍生物在生产治疗和预防骨损失和骨质疏松症药物中的用途 | |
| SK282103B6 (sk) | Farmaceutický prostriedok na liečenie endokrinopatií | |
| CZ212397A3 (en) | Use of 3,4-diphenylchromans for preparing pharmaceutical preparations for treating or prophylaxis of hyperlipoproteinaemia, hypertriacylglycerolaemia, hyperlipidaemia, hypercholesterolaemia, arteriosclerosis and reduction of blood sedimentation | |
| WO1994026768A1 (fr) | Promoteur d'osteogenese et remede contre l'osteoporose | |
| US6335372B1 (en) | Treatment of obsessive compulsive disorder | |
| WO2000041700A1 (fr) | Utilisation d'oestrogenes et de delta-gonadiene-21-ol-3,20-diones dans le traitement ou la prevention de maladies degeneratives du cerveau | |
| JP2650847B2 (ja) | 心臓保護活性を有する薬理組成物 | |
| JP2002534469A (ja) | エストロゲン及びデルタ−ゴナジエン−２１−オール−３，２０−ジオンの使用 | |
| CZ211897A3 (en) | Use of 3,4-diphenylchromans for preparing pharmaceutical preparations used for dilation of vessels | |
| KR100196445B1 (ko) | 신경보호활성을 갖는 알파-디하이드로에르고크립틴 약제학적 제제 | |
| SK3402000A3 (en) | Use of a substance primary activating the osteoblastic protein kinase c/intracellular calcium pathways of a subject | |
| CN115212194A (zh) | 纳多洛尔在制备治疗缺血/再灌注损伤药物及细胞保护药物中的应用 | |
| JP2002538122A (ja) | 天然に存在しないｆｐ選択的アゴニストおよび骨吸収抑制化合物を用いる骨体積の増加方法 | |
| Horowski et al. | Lisuride—a new drug for treatment of hyperprolactinaemic disorders | |
| JP2001511182A (ja) | ステロイドホルモンの永久に荷電された誘導体の増進された抗血管形成誘導活性 | |
| Frishman et al. | Antiarrhythmic Agents | |
| CZ2000808A3 (cs) | Použití selektivního FP agonisty, který se přirozeně nevyskytuje |